Dynamic Thermal Emission Control Based on Ultrathin Plasmonic Metamaterials Including Phase‐Changing Material GST
Dynamic thermal emission control has attracted growing interest in a broad range of fields, including radiative cooling, thermophotovoltaics and adaptive camouflage. Previous demonstrations of dynamic thermal emission control present disadvantages of either large thickness or requiring sustained electrical or thermal excitations. In this paper, an ultrathin (∼0.023λ, λ is the emission peak wavelength) metal‐insulator‐metal plasmonic metamaterial‐based zero‐static‐power mid‐infrared thermal emitter incorporating phase‐changing material GST is experimentally demonstrated to dynamically control the thermal emission. The electromagnetic modes can be continuously tuned through the intermediate phases determined by controlling the temperature. A typical resonance mode, which involves the coupling between the high‐order magnetic resonance and anti‐reflection resonance, shifts from 6.51 to 9.33 μm while GST is tuned from amorphous to crystalline phase. This demonstration will pave the way towards the dynamical thermal emission control in both the fundamental science field and a number of energy‐harvesting applications.
An ultrathin plasmonic thermal emitter is experimentally demonstrated to dynamically control thermal emission based on MIM plasmonic metamateirals. The dynamic low‐power‐consumption control is implemented by incorporating zero‐static‐power phase‐changing material Ge2Sb2Te5 (GST). The whole structure shows a total thickness of 550 nm (∼0.023λ), which is well below the subwavelength scale. This ultrathin plasmonic nanostructure combined with zero‐static‐power phase‐changing material paves a new way to dynamically control thermal emission.
Yurui Qu, Qiang Li, Kaikai Du, Lu Cai, Jun Lu, Min Qiu
Congenital myasthenic syndromes (CMS) are heterogeneous disorders in which the safety margin of neuromuscular transmission is impaired by one or more specific mechanisms. Since the advent of next‐generation sequencing methods, the discovery of novel CMS targets and phenotypes ha ... more
Myasthenia gravis (MG) with antibodies to muscle‐specific kinase (MuSK) is characterized by fluctuating fatigable weakness. In MuSK MG, involvement of bulbar muscles, neck, and shoulder and respiratory weakness are more prominent than in acetylcholine receptor (AChR) MG. MuSK au ... more
Because of the failure of many promising therapeutics identified in preclinical evaluation, funding sources have established guidelines for increased rigor in animal evaluations. The myasthenia gravis (MG) community of scientists has developed guidelines for preclinical assessme ... more
Smart skin that can respond to external stimuli could have important applications in medicine and robotics. Using only items found in a typical household, researchers have created multi-sensor artificial skin that's capable of sensing pressure, temperature, humidity, proximity, pH, and air ... more
Mercury contamination in water and on land is of worldwide concern due to its toxic effects on ecosystems and human health. Mercury toxicity is of particular concern to reptiles because they are currently experiencing population declines. Also, reptiles are ideal indicators of mercury conta ... more
A team of pioneering South Korean scientists have succeeded in producing the polymers used for everyday plastics through bioengineering, rather than through the use of fossil fuel based chemicals. This groundbreaking research, which may now allow for the production of environmentally consci ... more